Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with Osimertinib.
Yuxin MuXuezhi HaoKe YangDi MaShouzheng WangZiyi XuJunling LiPu-Yuan XingPublished in: Targeted oncology (2020)
Chemotherapy could be an effective option after osimertinib failure in unselected patients.
Keyphrases
- advanced non small cell lung cancer
- epidermal growth factor receptor
- end stage renal disease
- small cell lung cancer
- newly diagnosed
- chronic kidney disease
- prognostic factors
- squamous cell carcinoma
- tyrosine kinase
- peritoneal dialysis
- radiation therapy
- locally advanced
- combination therapy
- patient reported
- replacement therapy